The FDA has approved trastuzumab deruxtecan (T-DXd; Enhertu, Daiichi Sankyo/AstraZeneca) in combination with pertuzumab for the first-line treatment of unresectable or metastatic HER2-positive breast ...
The overall survival (OS) data has come in from the TROPION-Lung01 study of AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan (Dato-DXd) in lung cancer – and the result likely isn’t what they ...
AstraZeneca and Daiichi Sankyo have claimed FDA approval for a second antibody-drug conjugate (ADC) for breast cancer, hoping to build on the success of a partnership that already spawned a ...
Every year, we’re told that hip-hop is in crisis. But if you ask us, it feels like there’s too much heat to keep up with. What’s lost on the chart-watchers lamenting rap’s mainstream lull is that the ...
Recently, in casual conversations, I’ve been asked for my opinion about the October report that “No Rap Songs Are in the Billboard Hot 100’s Top 40 for the First Time Since 1990” more so than my ...
We should address the elephant in the room: hip-hop did not have a strong year on the charts. In fact, rap music had its worst showing in years. Back in October, it made headlines when—for the first ...
What does good rapping sound like in 2025? It depends on who you ask. It’s no secret that hip-hop is more splintered than ever, with different pockets and intersections thriving in their own ...
THE YEAR'S MOST POPULAR RAP SONGS, RANKED BY STREAMING ACTIVITY FROM DIGITAL MUSIC SOURCES TRACKED BY LUMINATE, RADIO AIRPLAY AUDIENCE IMPRESSIONS AS PROVIDED BY LUMINATE AND SALES DATA AS COMPILED BY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback